Dr. Stephen Nicholls
Over to biotech company AtheroNova, who has named Dr. Stephen Nicholls as Chair of its Clinical Advisory Board.
“Steve is one of the world's most respected authorities in the imaging of atherosclerosis," said Dr. Mark Wedel, Chief Medical Officer of AtheroNova. "We are profoundly fortunate and appreciative to benefit from his leadership and expertise as we move forward. His legacy in the battle against cardiovascular disease first at the Cleveland Clinic and now at SAHMRI is world renown and look forward to his contribution. In addition to the other recent additions at the Company, Steve's role is an exponential addition to our clinical developments efforts here at AtheroNova.”
AtheroNova has also recently appointed Dr. John Kastelein as its Co-Principal Investigator.
